MIST treatment for Prostate (REZUM/iTIND/Urolift)
MIST Treatment for Prostate (REZUM/iTIND/Urolift)
MIST therapy refers to Minimally Invasive Surgical Therapies for benign prostatic hyperplasia (BPH), offering less aggressive alternatives to traditional surgery like TURP. These procedures target enlarged prostate tissue to relieve urinary symptoms while minimizing recovery time and side effects.
Common MIST Procedures
MIST includes options like UroLift, which lifts prostate tissue away from the urethra, and Rezūm, which uses water vapor to shrink excess tissue. Both avoid cutting or removing prostate tissue, often performed under local anesthesia in outpatient settings. iTind and others like Butterfly devices are also available for specific prostate shapes.
Key Advantages
Patients experience preserved sexual function, with low risks of erectile dysfunction or ejaculatory issues compared to more invasive surgeries. Recovery is rapid, allowing quick return to activities, shorter hospital stays, and fewer complications like bleeding or incontinence. Studies show significant IPSS score reductions (up to 50-55%), improved urine flow, and quality of life over 4+ years.
These modalities are chosen on an individual basis for our patients especially for those prioritizing sexual health, or high-risk surgical candidates. Discuss with a urologist to match based on prostate size, symptoms, and preferences.